Aims of the Committee
Review any requests for changes to the IAC statutes and submit the current text and the proposed alterations for consideration to the Board of Directors
Responsibilities:
- Monitor legislative and regulatory events and communicate any updates to the board
- Examine and respond to questions on statute and bylaws of the academy and present requests for statutory changes to the board.
Chair
Dr Claire Bourgain, MIAC (Belgium)
Dr. Bourgain is Head of the Department of Pathology at Imelda Hospital, Bonheiden, Leuven, Belgium.
Members
Dr. Mousa Al-Abbadi, MD, FIAC (Jordan)
Dr. Mousa Al-Abbadi became an associate professor in 2007 and then moved to hold the position of Chief of Pathology at the James H. Quillen Veteran Administration Hospital in Johnson City, an affiliate with East Tennessee State University and became a professor of pathology in 2008.
In 2011, he moved to Saudi Arabia as a Professor of Pathology and Cytopathology at King Fahad Specialist Hospital – Dammam, Saudi Arabia. He then joined the pathology team at Sheikh Khalifa Medical City in Abu Dhabi, United Arab Emirates from 2015-2017. Recently, he moved back to University of Jordan, college of medicine. He served as the Chairperson of the Department of Pathology, Microbiology and Forensic Medicine (2021-2022).
Dr. Marianne Engels, MD, FIAC (Germany)
Dr. Engels is a past president of the German Society of Cytology and is now serving as
Secretary General of the German Society. She’s representing the German Society to the
European Federation of Cytology Societies (EFCS) and is now President of the EFCS, a title
which is linked to her function as congress president of the last European Congress of
Cytology which took place in Leipzig in 2024.
Dr. Dina Mody, MD, FIAC (USA)
Dr. Dina Mody is Director of Cytology at Houston Methodist Physician’s Organization
Donna russell, CFIAC (USA)
Donna Russell received her Master’s in Education from the University of Rochester Graduate School of Education and currently is the Education Coordinator of the Cytopathology Resident/Fellowship training program at the University of Rochester Medical Center in Rochester, New York. She has been an employee at UR Medicine for over 30 years. She is also the program director of the Master’s level Roswell Park Comprehensive Cancer Center/Daemen College School of Cytotechnology and is currently teaching her seventh class.
Dr. Paul VanderLaan, MD, PhD, MIAC (USA)
Dr. Paul VanderLaan is the Director of Surgical Pathology, Cytopathology, and Thoracic Pathology at the Beth Israel Deaconess Medical Center and is an Associate Professor of Pathology at Harvard Medical School. His clinical and research interests lie at the intersection of cytopathology and pulmonary pathology in the setting of both neoplastic and non-neoplastic lung disease, as well as thyroid cytology FNA reporting. He is Editor-in-Chief of the Journal of the American Society of Cytopathology (JASC), the co-editor of the 3rd edition of the Bethesda System for Reporting Thyroid Cytopathology, and the associate editor of the 6th edition of Cibas and Ducatman’s popular Cytology textbook.
Ex-Officio Members
dr. Syed Z. Ali, MD, FRCPath, FIAC (USA)
Prof. Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine as well as the Director of the Division of Cytopathology at The Johns Hopkins Hospital. He received his Pathology residency training at North Shore University Hospital/Cornell University in New York with fellowships in Oncologic Surgical Pathology at Memorial Sloan-Kettering Cancer Center in New York and Cytopathology at The Johns Hopkins Hospital in Baltimore.
Known globally as an innovative educator, Prof. Ali has well over 375 invited lectures, keynote speeches and visiting professorships all over the world. In collaboration with international societies and universities, he directs or co-directs several annual major cytopathology tutorials.
Prof. Ali has published extensively with over 335 peer-reviewed articles in major scientific journals, over 35 books, book chapters and electronic media. Known for his expertise in “Thyroid” and “Pancreatic” cytopathology, his monograph on “The Bethesda System for Reporting Thyroid Cytopathology” (now in its 3rd edition) has been translated in 8 languages and is extensively used in medical practice all over the world. He is the founding editor-in-chief of the Journal of the American Society of Cytopathology (JASC) and a past-President of the American Society of Cytopathology (ASC). Presently, he serves as the President of the International Academy of Cytology (IAC) and Chair of the International Board of Cytopathology of the IAC. He is a fellow of both the Royal College of Pathologists (UK) and the IAC. He is recipient of the ASC’s “Warren R. Lang Award” in 1996, “President’s Award” in 2012, “Excellence in Education Award” in 2015, the IAC’s “Maurice Goldblatt Award” in 2019, Papanicolaou Society of Cytopathology’s “LC Tao Educator of the Year Award” in 2022 and the ASC’s “Papanicolaou Award” in 2023.
Massimo Bongiovanni, MD, FIAC (Switzerland)
Dr. Bongiovanni is head of Cytopathology at SYNLAB Pathology in Lausanne, Switzerland. He is member of the Pathology Expert Group, at SYNLAB International, Member (MIAC) and then Fellow (FIAC) of the International Academy of Cytology since 2016. He is the author of more than 200 scientific articles and 15 book chapters. He was Vice President of the Swiss Cytology Society (2015-2021) and a member of the Endocrine Tumor Group of the European Organisation for Research and Treatment of Cancer (EORTC). He is associate editor of the journal Acta Cytologica and participates in the editorial board of the journal Diagnostic Cytopathology. He is currently co-chair of the scientific committee of the European Federation of Cytology Societies (EFCS).